First Allied Advisory Services’s Gilead Sciences GILD Stock Holding History

First Allied Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$4.99M	Buy	78,953 +5,326	+7%	+$369K	0.17%	135
2020 Q2	$5.67M	Sell	73,627 -12,457	-14%	-$955K	0.21%	113
2020 Q1	$6.44M	Buy	86,084 +7,645	+10%	+$528K	0.28%	86
2019 Q4	$5.08M	Sell	78,439 -21,366	-21%	-$1.39M	0.17%	142
2019 Q3	$6.35M	Sell	99,805 -24,748	-20%	-$1.62M	0.23%	110
2019 Q2	$8.42M	Sell	124,553 -6,118	-5%	-$402K	0.29%	77
2019 Q1	$8.53M	Sell	130,671 -4,473	-3%	-$297K	0.29%	74
2018 Q4	$8.54M	Sell	135,144 -32,460	-19%	-$2.27M	0.34%	61
2018 Q3	$13M	Buy	167,604 +14,493	+9%	+$1.09M	0.45%	38
2018 Q2	$10.8M	Buy	153,111 +68,614	+81%	+$4.85M	0.41%	43
2018 Q1	$6.4M	Sell	84,497 -17,062	-17%	-$1.36M	0.25%	104
2017 Q4	$7.28M	Sell	101,559 -6,765	-6%	-$514K	0.29%	78
2017 Q3	$8.75M	Buy	108,324 +5,330	+5%	+$408K	0.38%	58
2017 Q2	$7.29M	Buy	102,994 +11,824	+13%	+$787K	0.33%	71
2017 Q1	$6.23M	Sell	91,170 -7,190	-7%	-$506K	0.32%	71
2016 Q4	$7.04M	Buy	98,360 +463	+0.5%	+$34.4K	0.36%	70
2016 Q3	$7.75M	Buy	97,897 +5,119	+6%	+$416K	0.41%	51
2016 Q2	$7.73M	Sell	92,778 -2,082	-2%	-$185K	0.43%	45
2016 Q1	$8.69M	Buy	94,860 +1,248	+1%	+$113K	0.48%	40
2015 Q4	$9.48M	Buy	93,612 +9,898	+12%	+$1.03M	0.49%	44
2015 Q3	$8.21M	Sell	83,714 -75	-0.1%	-$8.33K	0.45%	48
2015 Q2	$9.85M	Buy	83,789 +18,991	+29%	+$2.08M	0.44%	50
2015 Q1	$6.37M	Buy	64,798 +9,150	+16%	+$929K	0.42%	45
2014 Q4	$5.23M	Sell	55,648 -19	-0%	-$1.97K	0.38%	52
2014 Q3	$5.94M	Buy	55,667 +7,350	+15%	+$720K	0.47%	39
2014 Q2	$3.99M	Buy	48,317 +15,296	+46%	+$1.19M	0.29%	80
2014 Q1	$2.33M	Buy	33,021 +3,110	+10%	+$244K	0.17%	151
2013 Q4	$2.27M	Buy	29,911 +11,719	+64%	+$816K	0.18%	155
2013 Q3	$1.14M	Buy	18,192 +5,510	+43%	+$329K	0.07%	278
2013 Q2	$647K	Buy	+12,682	New	+$661K	0.05%	373

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Allied Advisory Services's GILD Position: Q3 2020 in Review

First Allied Advisory Services increased its Gilead Sciences (GILD) stake by 7.2% in Q3 2020, buying an estimated $369K and bringing the position to 78,953 shares worth $4.99M. The position accounts for 0.17% of the portfolio, ranked #135.

First Allied Advisory Services first reported a position in GILD in Q2 2013 and has held it in 30 quarters since. The position peaked at $13M in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

First Allied Advisory Services held 78,953 shares of Gilead Sciences worth $4.99M as of Q3 2020.
First Allied Advisory Services bought 5,326 Gilead Sciences shares in Q3 2020, an estimated $369K.
Gilead Sciences made up 0.17% of First Allied Advisory Services's portfolio in Q3 2020, its #135 holding.
First Allied Advisory Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 30 quarters since.
First Allied Advisory Services's Gilead Sciences position peaked at $13M in Q3 2018.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.